NovoCure NVCR Stock
16.61 USD
{{ price }}
0.727719%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Medical Devices
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
1.83B USD
LOW - HIGH [24H]
15.44
-
17.4 USD
VOLUME [24H]
1.25M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.56 USD
NovoCure Price Chart
NovoCure NVCR Financial and Trading Overview
| NovoCure stock price | 16.61 USD |
| Previous Close | 45 USD |
| Open | 44.94 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1300 |
| Day's Range | 43.89 - 45.99 USD |
| 52 Week Range | 41.61 - 120.03 USD |
| Volume | 1.87M USD |
| Avg. Volume | 1.19M USD |
| Market Cap | 4.66B USD |
| Beta (5Y Monthly) | 0.795422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 90 USD |
NVCR Valuation Measures
| Enterprise Value | 4.29B USD |
| Trailing P/E | N/A |
| Forward P/E | -21.207731 |
| PEG Ratio (5 yr expected) | -0.38 |
| Price/Sales (ttm) | 8.924016 |
| Price/Book (mrq) | 10.786241 |
| Enterprise Value/Revenue | 8.213 |
| Enterprise Value/EBITDA | -30.942 |
Trading Information
NovoCure Stock Price History
| Beta (5Y Monthly) | 0.795422 |
| 52-Week Change | -24.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 120.03 USD |
| 52 Week Low | 41.61 USD |
| 50-Day Moving Average | 66.09 USD |
| 200-Day Moving Average | 74.96 USD |
NVCR Share Statistics
| Avg. Volume (3 month) | 1.19M USD |
| Avg. Daily Volume (10-Days) | 3.81M USD |
| Shares Outstanding | 106.21M |
| Float | 95.02M |
| Short Ratio | 10.78 |
| % Held by Insiders | 1.18% |
| % Held by Institutions | 81.01% |
| Shares Short | 8.08M |
| Short % of Float | 10.62% |
| Short % of Shares Outstanding | 7.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -26.97% |
| Operating Margin (ttm) | -28.39% |
| Gross Margin | 77.77% |
| EBITDA Margin | -26.54% |
Management Effectiveness
| Return on Assets (ttm) | -7.97% |
| Return on Equity (ttm) | -32.47% |
Income Statement
| Revenue (ttm) | 522.48M USD |
| Revenue Per Share (ttm) | 4.97 USD |
| Quarterly Revenue Growth (yoy) | -11.20% |
| Gross Profit (ttm) | 423.58M USD |
| EBITDA | -138675008 USD |
| Net Income Avi to Common (ttm) | -140948000 USD |
| Diluted EPS (ttm) | -1.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 958.04M USD |
| Total Cash Per Share (mrq) | 9.02 USD |
| Total Debt (mrq) | 586.3M USD |
| Total Debt/Equity (mrq) | 135.67 USD |
| Current Ratio (mrq) | 7.32 |
| Book Value Per Share (mrq) | 4.07 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 17.75M USD |
| Levered Free Cash Flow (ttm) | 164.19M USD |
Profile of NovoCure
| Country | United States |
| State | N/A |
| City | Saint Helier |
| Address | No. 4 The Forum |
| ZIP | JE2 4UF |
| Phone | 44 15 3475 6700 |
| Website | https://www.novocure.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 1320 |
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Q&A For NovoCure Stock
What is a current NVCR stock price?
NovoCure NVCR stock price today per share is 16.61 USD.
How to purchase NovoCure stock?
You can buy NVCR shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NovoCure?
The stock symbol or ticker of NovoCure is NVCR.
Which industry does the NovoCure company belong to?
The NovoCure industry is Medical Devices.
How many shares does NovoCure have in circulation?
The max supply of NovoCure shares is 109.92M.
What is NovoCure Price to Earnings Ratio (PE Ratio)?
NovoCure PE Ratio is now.
What was NovoCure earnings per share over the trailing 12 months (TTM)?
NovoCure EPS is -1.56 USD over the trailing 12 months.
Which sector does the NovoCure company belong to?
The NovoCure sector is Healthcare.
NovoCure NVCR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19098.57 USD — |
+0.1
|
— — | 18095.83 USD — | 19941.93 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7634.31 USD — |
+0.11
|
— — | 7233.89 USD — | 7972.89 USD — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1314.87 USD — |
-1.21
|
— — | 1267.2 USD — | 1347.29 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2497.76 USD — |
-0.11
|
— — | 2369.22 USD — | 2594.76 USD — | — - | — — |
| Nasdaq Next Generation 100 Inde NGX | 1052.53 USD — |
-0.4
|
— — | 1006.14 USD — | 1095.4 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3856.67 USD — |
-1.22
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
- {{ link.label }} {{link}}